Id |
Subject |
Object |
Predicate |
Lexical cue |
T44 |
10-18 |
SP_7 |
denotes |
COVID-19 |
T19296 |
10-18 |
SP_7 |
denotes |
COVID-19 |
T45 |
36-42 |
UBERON:0002405 |
denotes |
immune |
T3907 |
36-42 |
UBERON:0002405 |
denotes |
immune |
T46 |
43-56 |
GO:0065007 |
denotes |
dysregulation |
T65562 |
43-56 |
GO:0065007 |
denotes |
dysregulation |
T47 |
60-70 |
CL:0000235;GO:0042116 |
denotes |
macrophage |
T99154 |
60-70 |
CL:0000235;GO:0042116 |
denotes |
macrophage |
T48 |
71-81 |
GO:0042116 |
denotes |
activation |
T21216 |
71-81 |
GO:0042116 |
denotes |
activation |
T49 |
101-112 |
UBERON:0001004 |
denotes |
respiratory |
T35889 |
101-112 |
UBERON:0001004 |
denotes |
respiratory |
T50 |
160-163 |
PR:000029150 |
denotes |
HLA |
T52417 |
160-163 |
PR:000029150 |
denotes |
HLA |
T51 |
170-174 |
PR:000001889 |
denotes |
CD14 |
T73916 |
170-174 |
PR:000001889 |
denotes |
CD14 |
T52 |
175-184 |
CL:0000576 |
denotes |
monocytes |
T86003 |
175-184 |
CL:0000576 |
denotes |
monocytes |
T53 |
250-258 |
SP_7 |
denotes |
COVID-19 |
T91561 |
250-258 |
SP_7 |
denotes |
COVID-19 |
T54 |
262-266 |
PR:000001393 |
denotes |
IL-6 |
T288 |
262-266 |
PR:000001393 |
denotes |
IL-6 |
T55 |
275-286 |
DG_35 |
denotes |
Tocilizumab |
T45776 |
275-286 |
DG_35 |
denotes |
Tocilizumab |
T56 |
305-315 |
SP_7 |
denotes |
SARS-CoV-2 |
T71931 |
305-315 |
SP_7 |
denotes |
SARS-CoV-2 |
T57 |
334-347 |
GO:0065007 |
denotes |
dysregulation |
T97850 |
334-347 |
GO:0065007 |
denotes |
dysregulation |